Newmont
NEM NYSE Gold Financials FY2016βFY2025
Newmont's revenue rose 21.3% to $22.7 billion in fiscal 2025. Its net margin was 31.2%, up from 17.9% a year earlier. Free cash flow was $7.3 billion, up 146.5%. It paid out $3.4 billion in dividends and buybacks, 47% of free cash flow. The diluted share count fell 3.5%.
What Newmont does
No business description yet.
- Legal name
- NEWMONT CORPORATION
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001164727-26-000010
0001164727
Revenue and margins
Newmont had $22.7B of revenue in fiscal 2025, up 21.3% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $7.3B in fiscal 2025, 32.2% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Newmont returned $3.4B to shareholders in fiscal 2025, 47% of free cash flow. The diluted share count fell 3.5%.
Value Newmont yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of $2.7B and divides by 1,108.0M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 12.7x Β· peers 25.2x Β· sector 20.6x.
Balance sheet
Cash, debt and the ratios that show how comfortably Newmont can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $5.1B | $3.8B | $3.0B | $3.6B | $8.2B |
| Debt incl. finance leases | $6.3B | $6.1B | $9.4B | $9.0B | $5.6B |
| Net debt / EBITDA | 0.3x | 1.0x | 21.0x | 0.7x | β0.2x |
| Debt / equity | 0.3x | 0.3x | 0.3x | 0.3x | 0.2x |
| Interest coverage | 5.8x | 0.7x | β7.9x | 15.4x | 49.7x |
| Current ratio | 2.9x | 2.2x | 1.3x | 1.6x | 2.3x |
| Quick ratio | 2.9x | 2.2x | 1.3x | 1.6x | 2.3x |
| Total assets | $40.6B | $38.5B | $55.5B | $56.3B | $57.1B |
| Total liabilities | $18.7B | $18.9B | $26.3B | $26.2B | $23.1B |
| Shareholders' equity | $22.0B | $19.4B | $29.0B | $29.9B | $33.9B |
| Net debt (β = net cash) | $1.3B | $2.4B | $6.4B | $5.3B | β$2.7B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$6.7M
4 insiders
Of sales under plans
82%
$5.5M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 1, 2026 | Natascha ViljoenPresident & CEO, Director | Sold plan | 3,882 | $114.81 | $0.4M | Form 4 |
| Oct 1, 2026 | Peter TothEVP, Chief Sustain & Dev Off | Sold plan | 3,000 | $114.81 | $0.3M | Form 4 |
| Sep 1, 2026 | Natascha ViljoenPresident & CEO, Director | Sold plan | 3,882 | $123.00 | $0.5M | Form 4 |
| Sep 1, 2026 | Peter TothEVP, Chief Sustain & Dev Off | Sold plan | 3,000 | $123.00 | $0.4M | Form 4 |
| Aug 5, 2026 | Brian TaboltChief Financial Officer | Sold | 11,445 | $105.09 | $1.2M | Form 4 |
| Aug 5, 2026 | Natascha ViljoenPresident & CEO, Director | Sold plan | 7,764 | $104.00 | $0.8M | Form 4 |
| Aug 3, 2026 | Peter TothEVP, Chief Sustain & Dev Off | Sold plan | 3,000 | $93.45 | $0.3M | Form 4 |
| Jul 1, 2026 | Peter TothEVP, Chief Sustain & Dev Off | Sold plan | 3,000 | $92.38 | $0.3M | Form 4 |
| Jun 1, 2026 | Natascha ViljoenPresident & CEO, Director | Sold plan | 3,882 | $105.32 | $0.4M | Form 4 |
| Jun 1, 2026 | Peter TothEVP, Chief Sustain & Dev Off | Sold plan | 3,000 | $105.32 | $0.3M | Form 4 |
| May 1, 2026 | Peter TothEVP, Chief Sustain & Dev Off | Sold plan | 3,000 | $110.11 | $0.3M | Form 4 |
| May 1, 2026 | Peter WexlerEVP, CLO & Interim CFO | Sold plan | 13,378 | $110.11 | $1.5M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 3 / 8 | 7 / 8 | 8 / 8 |
| Accruals ratio | β11.2% | β5.4% | β5.7% |
| Altman Z'' | 0.95 | 2.26 | 3.95 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Newmont NEM | $114.4B | 21.3% | β | 32.2% | 20.6% | 12.7x | 8 | |
| Coeur Mining CDE | $13.9B | 96.4% | 34.2% | 32.2% | β | β | β | Compare β |
| Royal Gold RGLD | $19.4B | 43.2% | 61.9% | β | 9.7% | 25.2x | 6 | Compare β |
| Amcor AMCR | $21.4B | 56.6% | 8.1% | 5.2% | 6.6% | 19.4x | 6 | Compare β |
| Sherwin-Williams SHW | $82.9B | 2.1% | β | 11.3% | 19.9% | 31.1x | 6 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $6.7B | $7.4B | $7.3B | $9.7B | $11.5B | $12.2B | $11.9B | $11.8B | $18.7B | $22.7B |
| Research and development | $134M | $143M | $153M | $150M | $122M | $154M | $229M | $200M | $197M | $166M |
| Interest expense | $276M | $435M | $188M | $273M | $261M | $229M | $172M | $228M | $317M | $233M |
| Pretax income | β$220M | $1.1B | $738M | $3.7B | $3.1B | $1.1B | β$51.0M | β$2.0B | $4.6B | $11.3B |
| Income tax | $579M | $1.1B | $386M | $832M | $704M | $1.1B | $455M | $526M | $1.4B | $4.6B |
| Net income | β$629M | β$114M | $341M | $2.8B | $2.8B | $1.2B | β$429M | β$2.5B | $3.3B | $7.1B |
| Diluted EPS | β$1.18 | β$0.21 | $0.64 | $3.81 | $3.51 | $1.46 | β$0.54 | β$2.97 | $2.92 | $6.39 |
| Diluted shares | 0.53B | 0.54B | 0.54B | 0.74B | 0.81B | 0.80B | 0.80B | 0.84B | 1.15B | 1.11B |
| Cash flow | ||||||||||
| Cash from operations | $2.8B | $2.1B | $1.8B | $2.9B | $4.9B | $4.3B | $3.2B | $2.8B | $6.4B | $10.3B |
| Capital expenditure | $1.1B | $866M | $1.0B | $1.5B | $1.3B | $1.7B | $2.1B | $2.7B | $3.4B | $3.0B |
| Free cash flow | $1.7B | $1.3B | $795M | $1.4B | $3.6B | $2.6B | $1.1B | $97.0M | $3.0B | $7.3B |
| Depreciation and amortization | $1.2B | $1.3B | $1.2B | $2.0B | $2.3B | $2.3B | $2.2B | $2.1B | $2.6B | $2.5B |
| Stock-based compensation | $70.0M | $70.0M | $76.0M | $121M | $84.0M | $72.0M | $76.0M | $80.0M | $89.0M | $99.0M |
| Acquisitions | $6.0M | $15.0M | $140M | $127M | $0.0M | $328M | $15.0M | $668M | $0.0M | $0.0M |
| Share buybacks | $0.0M | $0.0M | $98.0M | $479M | $521M | $525M | $0.0M | $0.0M | $1.2B | $2.3B |
| Dividends paid | $67.0M | $134M | $301M | $889M | $834M | $1.8B | $1.7B | $1.4B | $1.1B | $1.1B |
| Dividends and buybacks | $67.0M | $134M | $399M | $1.4B | $1.4B | $2.3B | $1.7B | $1.4B | $2.4B | $3.4B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $2.8B | $3.3B | $3.4B | $2.5B | $5.8B | $5.1B | $3.8B | $3.0B | $3.6B | $8.2B |
| Total debt | $4.6B | $4.0B | $4.0B | $6.2B | $6.1B | $5.7B | $5.6B | $8.9B | $8.5B | $5.1B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $696M | $671M | $618M | $561M | $562M | $496M | $474M |
| Current assets | $4.7B | $5.1B | $5.3B | $6.3B | $8.5B | $7.7B | $6.5B | $7.5B | $12.3B | $13.1B |
| Current liabilities | $1.8B | $1.4B | $1.8B | $2.4B | $3.4B | $2.7B | $2.9B | $6.0B | $7.5B | $5.7B |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | $12.5B | $12.3B | $12.3B | $25.3B | $24.3B | $24.1B | $24.1B | $37.6B | $33.5B | $33.3B |
| Total assets | $21.1B | $20.6B | $20.7B | $40.0B | $41.4B | $40.6B | $38.5B | $55.5B | $56.3B | $57.1B |
| Total liabilities | $9.2B | $9.1B | $9.2B | $17.6B | $17.5B | $18.7B | $18.9B | $26.3B | $26.2B | $23.1B |
| Shareholders' equity | $10.7B | $10.5B | $10.5B | $21.4B | $23.0B | $22.0B | $19.4B | $29.0B | $29.9B | $33.9B |
| Margins | ||||||||||
| EBITDA margin | 18.9% | 37.5% | 29.5% | 60.8% | 49.6% | 30.0% | 19.4% | 2.6% | 40.0% | 62.2% |
| Net margin | β9.4% | β1.5% | 4.7% | 28.8% | 24.6% | 9.5% | β3.6% | β21.1% | 17.9% | 31.3% |
| FCF margin | 24.6% | 17.1% | 11.0% | 14.4% | 31.1% | 21.5% | 9.1% | 0.8% | 15.9% | 32.2% |
| Returns | ||||||||||
| Return on capital | 0.3% | 5.8% | 3.8% | 15.8% | 10.3% | 2.8% | 0.4% | β5.0% | 9.6% | 20.6% |
| Return on capital employed | 0.3% | 7.8% | 4.9% | 14.0% | 9.0% | 3.5% | 0.3% | β4.2% | 10.0% | 23.1% |
| Return on equity | β5.7% | β1.1% | 3.2% | 17.6% | 12.7% | 5.2% | β2.1% | β10.3% | 11.4% | 22.2% |
| Return on assets | β2.7% | β0.6% | 1.7% | 9.2% | 7.0% | 2.9% | β1.1% | β5.3% | 6.0% | 12.5% |
| Growth | ||||||||||
| Revenue growth | 10.3% | 10.0% | β1.7% | 34.3% | 18.0% | 6.3% | β2.5% | β0.9% | 58.2% | 21.3% |
| Net income growth | β385.9% | β | β | 722.6% | 0.9% | β58.8% | β136.8% | β | β | 111.6% |
| EPS growth | β374.4% | β | β | 495.3% | β7.9% | β58.4% | β137.0% | β | β | 118.8% |
| FCF growth | 98.2% | β23.9% | β36.8% | 76.5% | 155.2% | β26.7% | β58.5% | β91.1% | 2,952.6% | 146.5% |
| Share count change | 3.1% | 0.6% | 0.0% | 37.8% | 9.4% | β0.6% | β0.8% | 5.8% | 36.5% | β3.5% |
| Financial health | ||||||||||
| Net debt / EBITDA | 1.4x | 0.3x | 0.3x | 0.7x | 0.2x | 0.3x | 1.0x | 21.0x | 0.7x | β0.2x |
| Debt / equity | 0.4x | 0.4x | 0.4x | 0.3x | 0.3x | 0.3x | 0.3x | 0.3x | 0.3x | 0.2x |
| Interest coverage | 0.2x | 3.5x | 4.9x | 14.5x | 13.0x | 5.8x | 0.7x | β7.9x | 15.4x | 49.7x |
| Current ratio | 2.7x | 3.6x | 3.0x | 2.6x | 2.5x | 2.9x | 2.2x | 1.3x | 1.6x | 2.3x |
| Quick ratio | 2.7x | 3.6x | 3.0x | 2.6x | 2.5x | 2.9x | 2.2x | 1.3x | 1.6x | 2.3x |
| Capital allocation | ||||||||||
| Capex / revenue | 16.9% | 11.7% | 14.2% | 15.0% | 11.3% | 13.5% | 17.9% | 22.6% | 18.2% | 13.4% |
| Stock comp / revenue | 1.0% | 1.0% | 1.1% | 1.2% | 0.7% | 0.6% | 0.6% | 0.7% | 0.5% | 0.4% |
| Payouts / FCF | 4.1% | 10.7% | 50.2% | 97.5% | 37.9% | 86.9% | 160.3% | 1,458.8% | 80.8% | 46.7% |
| Quality scores | ||||||||||
| Piotroski F-score | 4.0 | 6.0 | 6.0 | 5.0 | 4.0 | 7.0 | 3.0 | 3.0 | 7.0 | 8.0 |
| Altman Z'' | 2.4 | 3.1 | 2.8 | 2.8 | 3.1 | 2.5 | 1.8 | 1.0 | 2.3 | 4.0 |
| Accruals ratio | β14.8% | β10.7% | β7.2% | β0.2% | β5.1% | β7.6% | β9.2% | β11.2% | β5.4% | β5.7% |
Source: SEC EDGAR XBRL filings (CIK 0001164727). Data updated October 22, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.